Literature DB >> 20597681

The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate.

Kwok Chiu Chang, Chi Chiu Leung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20597681     DOI： 10.1086/654806

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

2.  Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.

Authors:  Aula Abbara; Sarah Chitty; Jennifer K Roe; Rohma Ghani; Simon M Collin; Andrew Ritchie; Onn Min Kon; John Dzvova; Harriet Davidson; Thomas E Edwards; Charlotte Hateley; Matthew Routledge; Jim Buckley; Robert N Davidson; Laurence John
Journal:  BMC Infect Dis       Date:  2017-03-24       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.